GMF(SZ:002551) Sou Hu Cai Jing·2025-10-28 01:25Core Viewpoint - Shangrong Medical (002551.SZ) reported its Q3 2025 results, indicating a decline in institutional investor holdings and changes in public fund and foreign investor participation [1] Institutional Holdings - As of October 27, 2025, two institutional investors disclosed holdings in Shangrong Medical A-shares, totaling 6.0327 million shares, which represents 0.71% of the total share capital [1] - The combined institutional holding ratio decreased by 1.43 percentage points compared to the previous quarter [1] Public Fund Participation - One public fund, the Medical Device ETF, increased its holdings during this period, with an increase ratio of 0.24% [1] - A total of 46 public funds that did not disclose holdings in this period include notable funds such as Guojin Quantitative Selected A, Guojin Quantitative Multi-Factor A, and Huatai-PB CSI 2000 Index Enhanced A [1] Foreign Investor Attitude - The report noted that foreign institutions such as Goldman Sachs LLC and Barclays Bank PLC did not disclose their holdings in this period compared to the previous quarter [1]